{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:28:00Z","timestamp":1791581280639,"version":"4.3.4"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fonds National de la Recherche Scientifique\u2014FNRS","award":["7.4531.22"],"award-info":[{"award-number":["7.4531.22"]}]},{"name":"Fonds National de la Recherche Scientifique\u2014FNRS","award":["7.6509.24"],"award-info":[{"award-number":["7.6509.24"]}]},{"DOI":"10.13039\/501100005026","name":"Fondation contre le Cancer","doi-asserted-by":"publisher","award":["FAF-C\/2018\/1274"],"award-info":[{"award-number":["FAF-C\/2018\/1274"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Are ovarian tissue fragments from patients with BReast CAncer gene 1 (BRCA1)-mutated breast cancer (BC) more sensitive to carboplatin and\/or paclitaxel exposure compared to those from non-mutated patients with BC?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n Carboplatin and paclitaxel treatment showed similar gonadotoxicity, irrespective of the genetic background.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Studies have shown that mutations of BRCA1 gene negatively impact the ovarian reserve due to defects in DNA repair mechanisms. As a result, patients with BRCA germline mutations might be more vulnerable to chemotherapy-induced gonadotoxicity. Carboplatin and paclitaxel are known moderately gonadotoxic drugs, but the impact of their combination on fertility remains unclear, particularly in BRCA-mutated patients.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n Cryopreserved ovarian tissue fragments from patients with BC, either carrying a BRCA1 germline mutation (n\u2009=\u20094) or not (n\u2009=\u20094), were exposed to chemotherapy using two models: (i) in vitro culture or (ii) in vivo xenotransplantation model. First, thawed ovarian tissue fragments were cultured for 3 days with carboplatin (10\u2009\u00b5g\/ml), paclitaxel (1\u2009\u00b5M), carboplatin, and paclitaxel or vehicle (dimethyl sulfoxide). Next, ovarian tissue fragments from the same patients were xenografted into the peritoneum of immunodeficient mice, followed by 3-week injections with either carboplatin (50\u2009mg\/kg\/week) and paclitaxel (10\u2009mg\/kg\/every 3\u2009days) or saline solution as a control.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Ovarian cortex was processed for histological analyses to assess follicle activation and survival in both experimental models. Follicle counting and morphological assessment were performed to evaluate the rates of follicles at different developmental stages, as well as the rate of atretic follicles. Immunostainings were performed for follicle activation (KL and p-RPS6), apoptosis (Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay), and DNA repair mechanisms (\u03b3H2AX, RAD51, and DNA PKcs).<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n While chemotherapy exposure did not significantly affect the proportion of primordial follicles in vitro, an increase in the proportion of quiescent follicles was observed after xenografting in the treated conditions compared to their respective controls, regardless of the presence of a BRCA mutation (BRCA+: 79.6\u2009\u00b1\u20095.07% versus 35.4\u2009\u00b1\u20098.26%, P\u2009=\u20090.0003; BRCA\u2212: 81.8\u2009\u00b1\u200910.50% versus 17.9\u2009\u00b1\u200921.93%, P\u2009=\u20090.0014), reflecting the massive destruction of the pool of growing follicles. No difference was observed in the rate of atretic follicles, but the TUNEL assay revealed that chemotherapy, alone or in combination, increased DNA fragmentation rates (BRCA+: 37\u201349%; BRCA\u2212: 43\u201355%) compared to the control conditions (BRCA+: 13\u201319%; BRCA\u2212: 17\u201323%) both in vitro and in vivo. DNA repair mechanisms were affected following chemotherapy exposure, as evidenced by a significant increase in \u03b3H2AX-stained follicles in vitro (both populations) and in vivo (BRCA-mutated tissue) compared to the respective controls. Finally, chemotherapy had a similar impact on follicular atresia and apoptosis in both populations. However, BRCA-mutated tissue had lower rates of apoptotic (41% in BRCA+ versus 56% in BRCA\u2212; P\u2009=\u20090.0184) and \u03b3H2AX-positive follicles (20% in BRCA+ versus 42% in BRCA\u2212; P\u2009=\u20090.0142) than non-mutated fragments when exposed to carboplatin alone in vitro.<\/jats:p>\n <\/jats:sec>\n \n LARGE SCALE DATA<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Experiments on human tissue have limitations, particularly with rare material such as ovarian tissue from young BRCA-mutated patients donated for research. The study is limited by the small sample size and high intra- and inter-patient variability.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Studies on BRCA-mutated ovarian tissue are essential to better understand how BRCA mutations impact the ovarian reserve and respond to gonadotoxic treatments. Unexpectedly, this study suggested that follicles from young BRCA-mutated patients below 35 are not more sensitive to chemotherapy than the one from non-mutated patients, although DNA repair mechanisms seems to be differentially affected. Altogether, the results can help to provide appropriate fertility preservation counseling in BRCA1-mutated patients.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n This study is funded by T\u00e9l\u00e9vie, a grant of the Fonds National de la Recherche Scientifique\u2014FNRS (Grant Nos 7.4531.22 and 7.6509.24), the Fondation contre le Cancer (Grant No. FAF-C\/2018\/1274), and supported by Fonds Erasme.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deaf133","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T08:00:12Z","timestamp":1751011212000},"page":"1709-1719","source":"Crossref","is-referenced-by-count":1,"title":["Carboplatin and paclitaxel induced-gonadotoxicity on the ovarian reserve of young breast cancer patients with BRCA1<\/i> mutation"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1045-9912","authenticated-orcid":false,"given":"Joana","family":"Dias Nunes","sequence":"first","affiliation":[{"name":"Research Laboratory on Human Reproduction, Universit\u00e9 Libre de Bruxelles (ULB) , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-7034","authenticated-orcid":false,"given":"Elissavet","family":"Ntemou","sequence":"additional","affiliation":[{"name":"Research Laboratory on Human Reproduction, Universit\u00e9 Libre de Bruxelles (ULB) , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Van den Steen","sequence":"additional","affiliation":[{"name":"Research Laboratory on Human Reproduction, Universit\u00e9 Libre de Bruxelles (ULB) , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"Findikli","sequence":"additional","affiliation":[{"name":"Fertility Clinic, HUB Erasme Hospital , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Fastrez","sequence":"additional","affiliation":[{"name":"Department of Gynecology, HUB Erasme Hospital , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Delbaere","sequence":"additional","affiliation":[{"name":"Fertility Clinic, HUB Erasme Hospital , Brussels,","place":["Belgium"]},{"name":"Department of Gynecology, HUB Erasme Hospital , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino , Genoa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-9769","authenticated-orcid":false,"given":"Melody","family":"Devos","sequence":"additional","affiliation":[{"name":"Research Laboratory on Human Reproduction, Universit\u00e9 Libre de Bruxelles (ULB) , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-6565","authenticated-orcid":false,"given":"Isabelle","family":"Demeestere","sequence":"additional","affiliation":[{"name":"Research Laboratory on Human Reproduction, Universit\u00e9 Libre de Bruxelles (ULB) , Brussels,","place":["Belgium"]},{"name":"Fertility Clinic, HUB Erasme Hospital , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025090401513594400_deaf133-B1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/molehr\/gaaa008","article-title":"Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads","volume":"26","author":"Allen","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"2025090401513594400_deaf133-B2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13048-023-01259-2","article-title":"Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?","volume":"16","author":"Ayhan","year":"2023","journal-title":"J Ovarian Res"},{"key":"2025090401513594400_deaf133-B3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","article-title":"Biology of breast cancer in young women","volume":"16","author":"Azim","year":"2014","journal-title":"Breast Cancer Res"},{"key":"2025090401513594400_deaf133-B4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","article-title":"Role of the human RAD51 protein in homologous recombination and double-stranded-break repair","volume":"23","author":"Baumann","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"2025090401513594400_deaf133-B5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"2025090401513594400_deaf133-B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/jayao.2015.0024","article-title":"Fertility issues in adolescent and young adult cancer survivors","volume":"5","author":"Benedict","year":"2016","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2025090401513594400_deaf133-B7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not act\u0131vated in DNA damage-induced and Tap63-mediated oocyte apoptos\u0131s in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis"},{"key":"2025090401513594400_deaf133-B8","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025090401513594400_deaf133-B9","doi-asserted-by":"crossref","first-page":"e0144245","DOI":"10.1371\/journal.pone.0144245","article-title":"Cisplatin induces overactivation of the dormant primordial follicle through PTEN\/AKT\/FOXO3a pathway which leads to loss of ovarian reserve in mice","volume":"10","author":"Chang","year":"2015","journal-title":"PloS One"},{"key":"2025090401513594400_deaf133-B10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10549-012-1994-8","article-title":"Estrogen receptor \u03b1 attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors","volume":"134","author":"Chang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2025090401513594400_deaf133-B11","doi-asserted-by":"crossref","first-page":"e0136421","DOI":"10.1371\/journal.pone.0136421","article-title":"Low expression of Mfn2 is associated with mitochondrial damage and apoptosis of ovarian tissues in the premature ovarian failure model","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"2025090401513594400_deaf133-B12","first-page":"130","article-title":"DNA double strand break repair via non-homologous end-joining","volume":"2","author":"Davis","year":"2013","journal-title":"Transl Cancer Res"},{"key":"2025090401513594400_deaf133-B13","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/humrep\/del092","article-title":"Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report","volume":"21","author":"Demeestere","year":"2006","journal-title":"Hum Reprod"},{"key":"2025090401513594400_deaf133-B14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1472-6483(10)62074-3","article-title":"Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility","volume":"7","author":"Demeestere","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"2025090401513594400_deaf133-B15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/nar\/gkl010","article-title":"BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution","volume":"34","author":"Deng","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"2025090401513594400_deaf133-B16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/ijms25010204","article-title":"BRCA mutations and fertility preservation","volume":"25","author":"Dias Nunes","year":"2023","journal-title":"IJMS"},{"key":"2025090401513594400_deaf133-B17","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1096\/fj.202001461RR","article-title":"Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation","volume":"34","author":"Eldani","year":"2020","journal-title":"FASEB J"},{"key":"2025090401513594400_deaf133-B18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2217\/fon-2016-0032","article-title":"Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue","volume":"12","author":"Fabbri","year":"2016","journal-title":"Future Oncol"},{"key":"2025090401513594400_deaf133-B19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.breast.2021.09.006","article-title":"Ovarian reserve of women with and without BRCA pathogenic variants: a systematic review and meta-analysis","volume":"60","author":"Gasparri","year":"2021","journal-title":"Breast"},{"key":"2025090401513594400_deaf133-B20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","article-title":"Dynamics of follicular growth in the human: a model from preliminary results","volume":"1","author":"Gougeon","year":"1986","journal-title":"Hum Reprod"},{"key":"2025090401513594400_deaf133-B21","doi-asserted-by":"crossref","first-page":"bnaa020","DOI":"10.1210\/endrev\/bnaa020","article-title":"Implications of nonphysiological ovarian primordial follicle activation for fertility preservation","volume":"41","author":"Grosbois","year":"2020","journal-title":"Endocr Rev"},{"key":"2025090401513594400_deaf133-B22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0015-0282(01)01959-8","article-title":"Effect of paclitaxel on primordial follicular reserve in mice","volume":"76","author":"G\u00fccer","year":"2001","journal-title":"Fertil Steril"},{"key":"2025090401513594400_deaf133-B23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/jemt.22697","article-title":"In situ cultured preantral follicles is a useful model to evaluate the effect of anticancer drugs on caprine folliculogenesis","volume":"79","author":"Guerreiro","year":"2016","journal-title":"Microsc Res Tech"},{"key":"2025090401513594400_deaf133-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2014-1020","article-title":"Intraovarian control of early folliculogenesis","volume":"36","author":"Hsueh","year":"2015","journal-title":"Endocr Rev"},{"key":"2025090401513594400_deaf133-B25","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2007-02-073213","article-title":"Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during taxol treatment","volume":"110","author":"Janssen","year":"2007","journal-title":"Blood"},{"key":"2025090401513594400_deaf133-B26","first-page":"1707","article-title":"Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis","volume":"6","author":"Jin","year":"2013","journal-title":"Onco Targets Ther"},{"key":"2025090401513594400_deaf133-B27","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025090401513594400_deaf133-B28","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00404-022-06538-9","article-title":"Protective effect of edaravone on cisplatin-induced injury in rat ovary","volume":"306","author":"Kara","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"2025090401513594400_deaf133-B29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1535-7163.MCT-14-0474","article-title":"Efficacy of carboplatin alone and in combination with ABT888 in intracranial murine models of BRCA-mutated and BRCA-wild-type triple negative breast cancer","volume":"14","author":"Karginova","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2025090401513594400_deaf133-B30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"2025090401513594400_deaf133-B31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","article-title":"Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies","volume":"26","author":"Kim","year":"2019","journal-title":"Cell Death Differ"},{"key":"2025090401513594400_deaf133-B32","doi-asserted-by":"crossref","first-page":"pkac045","DOI":"10.1093\/jncics\/pkac045","article-title":"Chemotherapy regimens received by women with BRCA1\/2 pathogenic variants for early stage breast cancer treatment","volume":"6","author":"Kurian","year":"2022","journal-title":"JNCI Cancer Spectrum"},{"key":"2025090401513594400_deaf133-B33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann Oncol"},{"key":"2025090401513594400_deaf133-B34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of taxanes, endocrine therapy, and deleterious germline BRCA mutations on anti-M\u00fcllerian hormone levels in early breast cancer patients treated with anthracycline- and cyclophosphamide-based chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front Oncol"},{"key":"2025090401513594400_deaf133-B35","first-page":"63","article-title":"Weekly versus every-3-week carboplatin with weekly paclitaxel in neoadjuvant chemotherapy for triple-negative breast cancer: a retrospective analysis","volume":"14","author":"Landry","year":"2022","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2025090401513594400_deaf133-B36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3343\/alm.2020.40.2.114","article-title":"BRCA1\/BRCA2 pathogenic variant breast cancer: treatment and prevention strategies","volume":"40","author":"Lee","year":"2020","journal-title":"Ann Lab Med"},{"key":"2025090401513594400_deaf133-B37","doi-asserted-by":"crossref","first-page":"e12719","DOI":"10.1111\/cpr.12719","article-title":"Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden","volume":"53","author":"Li","year":"2020","journal-title":"Cell Prolif"},{"key":"2025090401513594400_deaf133-B38","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/jc.2017-00765","article-title":"Ovarian aging in women with BRCA germline mutations","volume":"102","author":"Lin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025090401513594400_deaf133-B39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/REP-19-0279","article-title":"Single and combined effects of cisplatin and doxorubicin on the human and mouse ovary in vitro","volume":"159","author":"Lopes","year":"2020","journal-title":"Reproduction"},{"key":"2025090401513594400_deaf133-B40","doi-asserted-by":"crossref","first-page":"825734","DOI":"10.3389\/ftox.2022.825734","article-title":"Maintenance of Sertoli cell number and function in immature human testicular tissues exposed to platinum-based chemotherapy\u2014implications for fertility restoration","volume":"4","author":"Matilionyte","year":"2022","journal-title":"Front Toxicol"},{"key":"2025090401513594400_deaf133-B41","doi-asserted-by":"crossref","first-page":"e70117","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PloS One"},{"key":"2025090401513594400_deaf133-B42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"2025090401513594400_deaf133-B43","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41598-022-05357-x","article-title":"Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene","volume":"12","author":"Ntemou","year":"2022","journal-title":"Sci Rep"},{"key":"2025090401513594400_deaf133-B44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025090401513594400_deaf133-B45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1095\/biolreprod.115.132290","article-title":"BRCA mutations, DNA repair deficiency, and ovarian aging","volume":"93","author":"Oktay","year":"2015","journal-title":"Biol Reprod"},{"key":"2025090401513594400_deaf133-B46","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.fertnstert.2020.01.033","article-title":"Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency","volume":"113","author":"Oktay","year":"2020","journal-title":"Fertil Steril"},{"key":"2025090401513594400_deaf133-B47","doi-asserted-by":"crossref","first-page":"19225","DOI":"10.1002\/cam4.6527","article-title":"A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: impact of BRCA pathogenic variants","volume":"12","author":"Oktay","year":"2023","journal-title":"Cancer Medicine"},{"key":"2025090401513594400_deaf133-B48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/1535-7163.MCT-16-0413","article-title":"MENA confers resistance to paclitaxel in triple-negative breast cancer","volume":"16","author":"Oudin","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2025090401513594400_deaf133-B49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/reprodmed4040023","article-title":"Exposure of early postnatal oocytes to chemotherapy alters the potential ovarian reserve, according to an ex vivo mouse model","volume":"4","author":"Ozcan","year":"2023","journal-title":"Reprod Med"},{"key":"2025090401513594400_deaf133-B50","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.fertnstert.2009.02.054","article-title":"Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist","volume":"93","author":"Ozcelik","year":"2010","journal-title":"Fertil Steril"},{"key":"2025090401513594400_deaf133-B51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO\u2013ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"key":"2025090401513594400_deaf133-B52","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2020.03.284","article-title":"ESO\u2013ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)","volume":"31","author":"Paluch-Shimon","year":"2020","journal-title":"Ann Oncol"},{"key":"2025090401513594400_deaf133-B53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1933719113506498","article-title":"Human ovarian tissue cortex surrounding benign and malignant lesions","volume":"21","author":"Pavone","year":"2014","journal-title":"Reprod Sci"},{"key":"2025090401513594400_deaf133-B54","volume-title":"GeneReviews\u00ae","author":"Petrucelli","year":"1993"},{"key":"2025090401513594400_deaf133-B55","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12958-018-0426-y","article-title":"Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice","volume":"16","author":"Qin","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"2025090401513594400_deaf133-B56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2025090401513594400_deaf133-B57","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3390\/ijms21186928","article-title":"Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics","volume":"21","author":"Schoch","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025090401513594400_deaf133-B58","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1200\/JCO.2023.41.16_suppl.10528","article-title":"Breast cancer: global patterns of incidence, mortality, and trends","volume":"41","author":"Sedeta","year":"2023","journal-title":"JCO"},{"key":"2025090401513594400_deaf133-B59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"2025090401513594400_deaf133-B60","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.3390\/ijms20215342","article-title":"The impact of chemotherapy on the ovaries: molecular aspects and the prevention of ovarian damage","volume":"20","author":"Sonigo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025090401513594400_deaf133-B61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1590\/S1984-82502014000400004","article-title":"Carboplatin: molecular mechanisms of action associated with chemoresistance","volume":"50","author":"Sousa","year":"2014","journal-title":"Braz J Pharm Sci"},{"key":"2025090401513594400_deaf133-B62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2025090401513594400_deaf133-B63","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1541-7786.MCR-20-0396","article-title":"Platinum-induced ubiquitination of phosphorylated H2AX by RING1A is mediated by replication protein A in ovarian cancer","volume":"18","author":"Sriramkumar","year":"2020","journal-title":"Mol Cancer Res"},{"key":"2025090401513594400_deaf133-B64","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2005.09.038","article-title":"MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks","volume":"123","author":"Stucki","year":"2005","journal-title":"Cell"},{"key":"2025090401513594400_deaf133-B65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp Anim"},{"key":"2025090401513594400_deaf133-B66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12916-020-01844-y","article-title":"Cisplatin and carboplatin result in similar gonadotoxicity in immature human testis with implications for fertility preservation in childhood cancer","volume":"18","author":"Tharmalingam","year":"2020","journal-title":"BMC Med"},{"key":"2025090401513594400_deaf133-B67","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025090401513594400_deaf133-B68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2019.01.016","article-title":"Platinum salts in the treatment of BRCA-associated breast cancer: a true targeted chemotherapy?","volume":"135","author":"Torrisi","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025090401513594400_deaf133-B69","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","article-title":"Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT trial","volume":"24","author":"Tutt","year":"2018","journal-title":"Nat Med"},{"key":"2025090401513594400_deaf133-B70","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1200\/JCO.2012.47.7893","article-title":"Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation","volume":"31","author":"Valentini","year":"2013","journal-title":"J Clin Oncol"},{"key":"2025090401513594400_deaf133-B71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/JOE-12-0153","article-title":"T3 preserves ovarian granulosa cells from chemotherapy-induced apoptosis","volume":"215","author":"Verga Falzacappa","year":"2012","journal-title":"J Endocrinol"},{"key":"2025090401513594400_deaf133-B72","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","article-title":"BRCA1 germline mutations may be associated with reduced ovarian reserve","volume":"102","author":"Wang","year":"2014","journal-title":"Fertil Steril"},{"key":"2025090401513594400_deaf133-B73","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol Biol Cell"},{"key":"2025090401513594400_deaf133-B74","doi-asserted-by":"crossref","first-page":"105262","DOI":"10.1016\/j.ebiom.2024.105262","article-title":"Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice","volume":"106","author":"Winship","year":"2024","journal-title":"eBioMedicine"},{"key":"2025090401513594400_deaf133-B75","doi-asserted-by":"crossref","first-page":"1025018","DOI":"10.3389\/fendo.2022.1025018","article-title":"The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: a review of current evidence","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025090401513594400_deaf133-B76","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mrd.23330","article-title":"Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo","volume":"87","author":"Xie","year":"2020","journal-title":"Mol Reprod Dev"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/9\/1709\/63731003\/deaf133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/9\/1709\/63731003\/deaf133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:51:51Z","timestamp":1756965111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/9\/1709\/8196984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":76,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,7,11]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf133","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,11]]}}}